The concurrent increase in IL-6 and IL-8 levels post-treatment suggests a common regulatory mechanism, such as one involving nuclear factor-κB, which plays an important role in the development and progression of head and neck SCC (HNSCC) [36]. Here, CXCL8 is linked to head and neck squamous cell carcinoma.